4//SEC Filing
Kiernan Jane E 4
Accession 0001562180-22-005626
CIK 0001603756other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 8:20 PM ET
Size
13.8 KB
Accession
0001562180-22-005626
Insider Transaction Report
Form 4
Axonics, Inc.AXNX
Kiernan Jane E
Director
Transactions
- Exercise/Conversion
Common Stock
2021-08-05$34.10/sh+4,167$142,095→ 21,761 total - Sale
Common Stock
2022-07-05$60.00/sh−5,250$315,000→ 14,761 total - Exercise/Conversion
Common Stock
2021-08-05$21.04/sh+10,000$210,400→ 17,594 total - Sale
Common Stock
2022-04-01$62.71/sh−1,750$109,743→ 20,011 total - Exercise/Conversion
Stock Options (Right to buy)
2021-08-05−4,167→ 0 totalExercise: $34.10Exp: 2029-08-22→ Common Stock (4,167 underlying) - Exercise/Conversion
Stock Options (Right to buy)
2021-08-05−10,000→ 0 totalExercise: $21.04Exp: 2029-04-08→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]The shares subject to the option will vest in full on August 22, 2020.
- [F3]The shares subject to the option will vest in full on April 8, 2020.
Documents
Issuer
Axonics, Inc.
CIK 0001603756
Entity typeother
Related Parties
1- filerCIK 0001379171
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 8:20 PM ET
- Size
- 13.8 KB